As internal validity of our label-free MS approach, we performed immunoblotting on whole hippocampal tissue of three upregulated proteins related to the cadherin-catenin complex (i.e., CTNNB1, JUP, and CDH2) in 15 SD patients and 15 controls from our initial MS cohort. This evidence concerns the gene CDH17 and Salla disease.